Loading organizations...
Key people at InvestSud.
InvestSud was founded in 2007 by Juan Eyzaguirre Letelier (CEO & Founder).
InvestSud operates as a risk capital partner, providing permanent capital to small and medium-sized enterprises (SMEs) within the Belgian provinces of Liège, Namur, and Luxembourg. The firm functions beyond traditional investment, leveraging an experienced team to foster innovation and development through human-centric, responsible, and sustainable strategies. This approach positions InvestSud as a strategic advisor, actively shaping the growth trajectories of its portfolio companies.
Established in 1983, InvestSud originated from the insight that regional SMEs needed a dedicated, long-term financial partner deeply integrated locally. Its formation addressed a critical gap by offering accessible risk capital coupled with strategic guidance. Over four decades, the company has consistently supported entrepreneurs, helping them navigate growth, market evolution, and business transmission with a localized and enduring commitment.
InvestSud primarily serves ambitious entrepreneurs leading SMEs in its defined operational regions. The company's vision is to be an "Ambition Amplifier," empowering partners to scale more effectively, accelerate development, and seamlessly integrate sustainability into their operations. This forward-looking commitment aims to cultivate a resilient, inspiring entrepreneurial ecosystem, ensuring enduring impact within its communities.
InvestSud was founded in 2007 by Juan Eyzaguirre Letelier (CEO & Founder).
Key people at InvestSud.
InvestSud has 7 tracked investments across 6 companies. The latest tracked deal is $24.2M Seed in Enodia Therapeutics in January 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 8, 2026 | Enodia Therapeutics | $24.2M Seed | Florian Denis, Olivier Martinez | Valentin Tonnel, Daniel Sobral, Macsf, Mission BioCapital, Sambrinvest |
| Dec 12, 2023 | Samabriva | $4.3M Series A | Investsud, Eric Brandt | — |
| Sep 4, 2023 | cikisi | $2.9M Pre-Series A | Marc Mommaerts | Pierre Hermant, Sambrinvest |
| Jan 19, 2023 | DeuterOncology | $6.1M Series A | Investsud, Newton Biocapital, Noshaq | — |
| Jan 18, 2023 | Synergia Medical | $4.1M Series B Extension | — | Jacques Berrebi, Invest.bw, Newton Biocapital, Sfpi, Sriw, Theclubdeal |
| Nov 3, 2022 | Novadip Biosciences | $23.6M Series B | — | Olivier VAN DER Rest, Pierre Drion, CR CP Life Science Fund, Fund+, Sriw, Vives Louvain Technology Fund |
| Oct 28, 2021 | Novadip Biosciences | $22.1M Series B | Jason Zhou | Fund+, Invest.bw, Franssen Christina, Vives Louvain Technology Fund |